NCT01071772View on ClinicalTrials.gov

The Effect of Hyperglycemia on LV Function and Exercise Capacity in Diabetics With and Without Heart Failure.

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Heart FailureType 2 Diabetes
Interventions
DRUG

insulin

There will be used individual intravenous insulin (actrapid) infusion to prevent non-intended hyperglycemia.

Trial Locations (1)

8200

Department ofCardiology, Aarhus University Hospital, Skejby, Aarhus

Sponsors

Collaborators (1)

Danish Heart Foundation
All Listed Sponsors
collaborator

Danish Heart Foundation

OTHER

collaborator

Region midtjyllands sundhedsvidenskabelige forskningsfond

UNKNOWN

lead

University of Aarhus

OTHER